Jordan Feld, MD, MPH, FRCP(C)

Professor of Medicine,
University of Toronto

Saturday, April 2, 2022

8:05 am - 8:25 am
 

A Look Back at Hepatitis C and Forward to Hepatitis B

As we all know, hepatitis C virus (HCV) treatment has evolved dramatically in the last decade, giving us the potential to eliminate this public health problem over the next decade. During that same period, we have seen little progress in therapy for hepatitis B virus (HBV); however HBV is the new HCV with very active therapeutic development. I will discuss the remaining challenges in HCV and then explain why HBV cure won’t be as simple as HCV cure but describe the efforts underway to get there.

Dr. Feld trained in GI and Hepatology at the University of Toronto and did post-doctoral training in the Liver Diseases Branch at the National Institutes of Health in laboratory and clinical research in viral hepatitis.  After completing a Masters in Public Health at the Johns Hopkins Bloomberg School of Public Health, he returned to Toronto. He is a Professor of Medicine at the University of Toronto and holds the R. Phelan Chair in Translational Liver Research as a clinician-scientist at the Toronto Centre for Liver Disease in the Toronto General Hospital where he leads a large clinical and translational research program focused primarily on viral hepatitis and its complications.